Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Silo Pharma, Inc. (SILO) had Return on Equity of -22.17% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.02M |
|
$-1.11M |
|
$0.02M |
|
$-0.00M |
|
$1.17M |
|
$-1.15M |
|
$0.04M |
|
$-1.11M |
|
$-1.11M |
|
$-1.11M |
|
$-1.11M |
|
$-1.11M |
|
$-1.11M |
|
$-1.15M |
|
$-1.15M |
|
9.33M |
|
9.33M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$6.16M |
|
-- |
|
$0.22M |
|
$6.38M |
|
$0.71M |
|
-- |
|
$0.67M |
|
$1.38M |
|
$5.01M |
|
$4.79M |
|
$5.01M |
|
10.46M |
|
| Cash Flow Statement Financials | |
$-3.88M |
|
$1.16M |
|
$2.73M |
|
$3.91M |
|
$3.92M |
|
$0.01M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.77% |
|
-6388.16% |
|
-6388.16% |
|
-- |
|
-6160.54% |
|
-6160.54% |
|
$-3.88M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-22.17% |
-23.19% |
|
-17.39% |
|
-22.17% |
|
$0.48 |
|
$-0.42 |
|
$-0.42 |
|